anti-obesity medicine

Bio & Pharma Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Steel POSCO to sell entire stake in Nippon Steel, ending equity ties

POSCO Holdings Inc. has decided to sell its entire stake in Nippon Steel Corp., according to industry sources on Wednesday, marking the end of their...

Bio & Pharma Chong Kun Dang to build new plant for foray into biologics market

Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...

Steel Dongkuk to file anti-dumping petition vs Chinese color steel imports

Dongkuk Coated Metal Co. and SeAh Steel Corp. are set to file an anti-dumping complaint against Chinese rivals in March as the country plans to impo...

Steel South Korea to levy 38% anti-dumping duties on Chinese steel products

South Korea plans to impose up to 38% provisional anti-dumping duties on Chinese hot-rolled steel plates starting next month, judging that those pro...

Steel Korea to probe Chinese, Japanese steel imports over anti-dumping claims

South Korea is set to launch an anti-dumping investigation into hot-rolled steel imports from China and Japan, according to government and industry ...

Steel South Korea’s steel imports from China at 7-year high

South Korea’s imports of steel products from China climbed to their highest level in seven years despite a decrease in its total steel imports...

Paper Korean paper makers to file anti-dumping complaint vs Japanese rivals

South Korean corrugated cardboard sheet makers such as Asia Paper Manufacturing Co. have decided to file an anti-dumping complaint against Japanese ...

Bio & Pharma SK Pharmteco bags obesity treatment deal worth up to $1.4 bn

SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...

Bio & Pharma Hanmi Pharma to move up launch of anti-obesity drug

South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...

Energy Czech anti-trust body puts signing of nuclear power deal on hold

The Czech anti-trust body put a temporary block on the conclusion of a contract with Korea Hydro & Nuclear Power Co. (KHNP) for the construction...

Bio & Pharma Celltrion's anti cancer drugs hold 90% market share in C.America

South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....

Business & Politics South Korea scraps anti-nuclear policy with approval of two nuclear plants

South Korea has approved the construction of two nuclear power plants, officially ending its anti-nuclear policy pursued by the previous Moon Jae-in...

Chemical Industry Samhwa Paint launches anti-rust product Knok-Stop

South Korea's Samhwa Paint Industrial said on Wednesday that it has introduced a new water-based primer, Knok-Stop, designed to convert rust on meta...

Bio & Pharma Yuhan’s lung cancer drug clears FDA hurdle for global debut

A new lung cancer treatment developed by South Korea’s Yuhan Corp. has secured approval from the US Food and Drug Administration (FDA) as a co...

Regulations S.Korea, China's technology leak, anti-dumping disputes surge

South Korean companies are getting tough on anti-dumping and patent infringement cases as they feel threatened by the intensifying price competition...

ESG LG Energy Solution acquires anti-bribery certification

South Korea's LG Energy Solution Ltd. announced on Thursday that it achieved ISO 37001 certification, an international standard for anti-bribery man...

Chemical Industry Lotte Chemical develops anti-thermal runaway material

Lotte Chemical Corp., South Korea’s second-largest petrochemicals company seeking to ramp up value-added advanced materials production, has de...

E-commerce Coupang fined $102 mn for alleged search algorithm manipulation

Coupang Inc., South Korea’s largest e-commerce platform, was fined 140 billion won ($102 million) on Thursday for allegedly manipulating searc...

Bio & Pharma Handok gets Biocon's obesity drug exclusive distribution in S.Korea

South Korean pharmaceutical company Handok Inc. announced on Friday that it signed an exclusive domestic sales and distribution agreement with India...

Bio & Pharma S.Korean anti-obesity drugmakers eye niche demand

The global weight management market has entered a new chapter following the arrival of blockbuster weight-loss medication Wegovy, and South Korean l...

Healthcare Korea’s booming medical tourism: Skin care, plastic surgery in demand

The number of foreign patients visiting South Korea for medical tourism hit a record high last year, driven by those who traveled to Korea for skin ...

Bio & Pharma Vivid Health gets seed round from Kakao Ventures

Vivid Health, a South Korean startup that operates an obesity treatment management platform announced on Wednesday that it got a seed round investme...

Bio & Pharma Daewoong gets stem cell facility license in Indonesia

South Korea's Daewoong Pharmaceutical announced on Tuesday that its subsidiary Daewoong Biologics Indonesia has obtained a stem cell Lab Operational...

Korean Investors Samsung Asset to launch S.Korea's first obesity treatment ETF

Korea Exchange announced on Thursday that it will list Samsung Asset Management's "KODEX Global Obesity Treatment Top 2 Plus exchange-traded fund (E...

Bio & Pharma Kobiolabs gets Chinese patent for obesity treatment strain

South Korean microbiome-based new drug development company Kobiolabs Co. announced on Wednesday that it has a patent for its obesity treatment strai...

Steel Korean steelmakers mull anti-dumping suit vs Chinese, Japanese firms

Under growing pressure from increased imports of cheap Chinese and Japanese steel products, South Korean steelmakers are considering filing an anti-...

Bio & Pharma Kobiolabs gets US patent for oral obesity drug candidate

Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...

Bio & Pharma Inventage Lab, Yuhan to co-work for obesity treatment

South Korea’s Inventage Lab Inc. announced on Friday that it has signed a joint development agreement with Yuhan Corp. for a long-acting inj...

Bio & Pharma LG Chem out-licenses obesity drug candidate to US firm

LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...